Accelerate Your Exosome Development Timeline: Cell Bio to Unveil Key Analytical Technologies
Exhibitor: CELL-BIO BIOTECHNOLOGY CO., LTD.
Date: 2025-07-14
Booth No.: L230
TAIPEI, Taiwan – July 14, 2025
As exosomes emerge as the next frontier in drug delivery and diagnostics, the standardization of their development and quality control has become a critical success factor. To meet this challenge, Cell Bio Biotechnology will host the seminar "Accelerating the Exosome Development Timeline: An Integrated Workflow from Process Optimization to Efficient Analysis" at BioAsia 2025 on July 24. The session will feature Dr. Pete Serbedzija, Business Development Manager for Asia Pacific at ChemoMetec, and Duncan Griffiths, CEO of Hyperion Analytical, who will jointly explain how to establish a robust and efficient analytical workflow.
This seminar will address the core pain points of exosome development through two key presentations:
Talk 1: Beyond "Good Enough": Why Precise Cell Counting is the First Step to Successful Cell Product Development Dr. Pete Serbedzija will explain how stable and consistent starting cell quality is the foundation for ensuring batch-to-batch consistency in exosome yield and potency. He will share how to leverage ChemoMetec's gold-standard cell counters to fundamentally stabilize cell culture quality and eliminate the inaccuracies of traditional counting methods, thereby building a solid base for downstream process optimization.
Talk 2: Unlocking Key Quality Attributes of Exosomes: In-depth Characterization and Application of High-Resolution NTA Once CQAs for exosomes are defined, their precise measurement becomes the next hurdle. Duncan Griffiths, CEO of Hyperion Analytical, will provide an in-depth look at high-resolution Nanoparticle Tracking Analysis (NTA). He will demonstrate how this technology provides not just particle size and concentration, but also deeper insights into critical metrics like purity and stability, helping researchers quickly identify optimal purification and production conditions.
"We see many teams spending excessive time on trial-and-error in their exosome process development," stated Glenn Yang, CTO at Cell Bio Biotechnology. "The 'integrated workflow' concept we are introducing connects upstream precision cell counting with downstream high-resolution NTA, creating a data-driven optimization cycle. This can dramatically shorten development timelines, reduce the risk of failure, and help bring Taiwan's innovations to market faster."
Event Details:
-
Seminar: Accelerating the Exosome Development Timeline: An Integrated Workflow from Process Optimization to Efficient Analysis
-
Speakers:
-
Dr. Pete Serbedzija, Business Development Manager - Asia Pacific, ChemoMetec
-
Duncan Griffiths, CEO, Hyperion Analytical
-
-
Date & Time: Thursday, July 24, 2025, 2:00 PM - 2:50 PM
-
Location: Room 505C, TaiNEX 1, Taipei
-
Registration: https://forms.gle/RZAsdwQovZo3DohdA
About Cell Bio Biotechnology
Cell Bio Biotechnology is a leading supplier in Taiwan's regenerative medicine and cell research sectors, dedicated to introducing the world's most advanced instruments and technologies. We provide comprehensive solutions for clients from basic research to clinical applications. More than just a distributor, we are a trusted partner, empowering our clients to overcome challenges and drive innovation through professional technical support and expert consulting services.
More Exhibitor's Press Release
- GoldenBiotech Seminar:Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 GOLDEN BIOTECHNOLOGY CORP. / 2025-07-17
- GlobalBio: 國鼎生技-開發Antroquinonol 造福抗癌研究治療 GOLDEN BIOTECHNOLOGY CORP. / 2025-07-17
- Focusing on dementia and brain health APN LIFESCIENCES INC / 2025-07-16
- Conquering the Final Hurdle of Cell Therapy Commercialization: Sony Senior Manager to Share Exclusiv CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-07-16
- Indiana - America's Life Sciences Powerhouse INDIANA ECONOMIC DEVELOPMENT CORPORATION, TAIWAN OFFICE / 2025-07-16
- Urine-Based Cancer Testing: Vitae Biomedical Pioneers a Non-Invasive Path to Lung Cancer Detection VITAE BIOMEDICAL CO. LTD. / 2025-07-16
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-07-15
- MabPlex : ONE-STOP CDMO FOR BIOPHARMACEUTICALS MABPLEX INTERNATIONAL CO., LTD. / 2025-07-15
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2025-07-15
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2025-07-15
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2025-07-15
- LiZhong Pathology Laboratory Achieves ISO/IEC 17025 Accreditation, Reaching International Standards BIOTNA, INC. / 2025-07-14
- VP-Motion is Japan’s leading AI-powered human behavior analysis software JYTC CO., LTD. / 2025-07-13
- Igus and JYTC walk together for better options. (German beer limited served daily) JYTC CO., LTD. / 2025-07-13
- Why choose Mecademic for robotic lab automation? JYTC CO., LTD. / 2025-07-13
- National Yang Ming Chiao Tung University’s Innovative Biotech and Medical Technologies NATIONAL YANG MING CHIAO TUNG UNIVERSITY / 2025-07-11
- Your Invitation to Innovation – Booth M412 Forum MAJOR SCIENCE CO.,LTD / 2025-07-09
- Cell Bio Biotechnology to Host Three International Authorities at BioAsia 2025, Unveiling a New Era CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-07-09
- Rooted in Mountains, Climbing the Peaks. BIOMEDICAL TRANSLATION RESEARCH CENTER, ACADEMIA SINICA (NATIONAL BIOTECHNOLOGY RESEARCH PARK) / 2025-07-09
- Honya’s MiSaver: A New Frontier in Treating Heart Damage After Heart Attacks HONYA MEDICAL CO., LTD. / 2025-07-08